Literature DB >> 20837823

Spreading depolarization: a possible new culprit in the delayed cerebral ischemia of subarachnoid hemorrhage.

Lewis Z Leng1, Matthew E Fink, Costantino Iadecola.   

Abstract

Aneurysmal subarachnoid hemorrhage (SAH) is a devastating disease with a high mortality and morbidity rate. Gradual improvements have been made in the reduction of mortality rates associated with the disease during the last 30 years. However, delayed cerebral ischemia (DCI), the major delayed complication of SAH, remains a significant contributor to mortality and morbidity despite substantial research and clinical efforts. During the last several years, the predominant role of cerebral vasospasm, the long-accepted etiologic factor behind DCI, has been questioned. It is now becoming increasingly clear that the pathophysiology underlying DCI is multifactorial. Cortical spreading depression is emerging as a likely factor in this complex web of pathologic changes after SAH. Understanding its role after SAH and its relationship with the other pathologic processes such as vasospasm, microcirculatory dysfunction, and microemboli will be vital to the development of new therapeutic approaches to reduce DCI and improve the clinical outcome of the disease.

Entities:  

Mesh:

Year:  2010        PMID: 20837823      PMCID: PMC3998646          DOI: 10.1001/archneurol.2010.226

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  53 in total

1.  Vasospasm after subarachnoid hemorrhage: utility of perfusion CT and CT angiography on diagnosis and management.

Authors:  M Wintermark; N U Ko; W S Smith; S Liu; R T Higashida; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

2.  Cortical spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex.

Authors:  Martin Fabricius; Susanne Fuhr; Robin Bhatia; Martyn Boutelle; Parastoo Hashemi; Anthony J Strong; Martin Lauritzen
Journal:  Brain       Date:  2005-12-19       Impact factor: 13.501

Review 3.  Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review.

Authors:  V L Feigin; G J Rinkel; A Algra; M Vermeulen; J van Gijn
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

4.  Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage.

Authors:  Alejandro A Rabinstein; Stephen Weigand; John L D Atkinson; Eelco F M Wijdicks
Journal:  Stroke       Date:  2005-04-14       Impact factor: 7.914

5.  Morphological changes of intraparenchymal arterioles after experimental subarachnoid hemorrhage in dogs.

Authors:  H Ohkuma; K Itoh; S Shibata; S Suzuki
Journal:  Neurosurgery       Date:  1997-07       Impact factor: 4.654

6.  Hyperglycemia after SAH: predictors, associated complications, and impact on outcome.

Authors:  Jennifer A Frontera; Andres Fernandez; Jan Claassen; Michael Schmidt; H Christian Schumacher; Katja Wartenberg; Richard Temes; Augusto Parra; Noeleen D Ostapkovich; Stephan A Mayer
Journal:  Stroke       Date:  2005-12-08       Impact factor: 7.914

7.  Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements.

Authors:  B D Murphy; A J Fox; D H Lee; D J Sahlas; S E Black; M J Hogan; S B Coutts; A M Demchuk; M Goyal; R I Aviv; S Symons; I B Gulka; V Beletsky; D Pelz; V Hachinski; R Chan; T-Y Lee
Journal:  Stroke       Date:  2006-06-08       Impact factor: 7.914

Review 8.  Calcium antagonists for aneurysmal subarachnoid haemorrhage.

Authors:  G J E Rinkel; V L Feigin; A Algra; W M van den Bergh; M Vermeulen; J van Gijn
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

9.  Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage.

Authors:  Sarah C Jost; Michael N Diringer; Allyson R Zazulia; Tom O Videen; Venkatesh Aiyagari; Robert L Grubb; William J Powers
Journal:  J Neurosurg       Date:  2005-07       Impact factor: 5.115

10.  Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.

Authors:  Peter Vajkoczy; Bernhard Meyer; Stefan Weidauer; Andreas Raabe; Claudius Thome; Florian Ringel; Volker Breu; Peter Schmiedek
Journal:  J Neurosurg       Date:  2005-07       Impact factor: 5.115

View more
  21 in total

1.  Stroke: disappointing results for clazosentan in CONSCIOUS-2.

Authors:  Philip M Meyers; E Sander Connolly
Journal:  Nat Rev Neurol       Date:  2011-10-18       Impact factor: 42.937

2.  Timing of Mean Transit Time Maximization is Associated with Neurological Outcome After Subarachnoid Hemorrhage.

Authors:  J Caspers; C Rubbert; B Turowski; D Martens; D C Reichelt; R May; J Aissa; D Hänggi; N Etminan; C Mathys
Journal:  Clin Neuroradiol       Date:  2015-05-05       Impact factor: 3.649

Review 3.  Noninvasive Neuromonitoring: Current Utility in Subarachnoid Hemorrhage, Traumatic Brain Injury, and Stroke.

Authors:  Luisa Vinciguerra; Julian Bösel
Journal:  Neurocrit Care       Date:  2017-08       Impact factor: 3.210

4.  Triggers for aggressive interventions in subarachnoid hemorrhage.

Authors:  Nino Stocchetti
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

5.  Impact of percutaneous transluminal angioplasty for treatment of cerebral vasospasm on subarachnoid hemorrhage patient outcomes.

Authors:  Rakesh Khatri; Muhammad Zeeshan Memon; Haralabos Zacharatos; Ather M Taqui; Mushtaq H Qureshi; Gabriela Vazquez; M Fareed K Suri; Gustavo J Rodriguez; Ramachandra P Tummala; Mustapha A Ezzeddine; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

6.  Inversion of neurovascular coupling by subarachnoid blood depends on large-conductance Ca2+-activated K+ (BK) channels.

Authors:  Masayo Koide; Adrian D Bonev; Mark T Nelson; George C Wellman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

7.  Controversy: does prevention of vasospasm in subarachnoid hemorrhage improve clinical outcome?

Authors:  Michael N Diringer
Journal:  Stroke       Date:  2013-06       Impact factor: 7.914

8.  A non-human primate model of aneurismal subarachnoid hemorrhage (SAH).

Authors:  Ryszard M Pluta; John Bacher; Boris Skopets; Victoria Hoffmann
Journal:  Transl Stroke Res       Date:  2014-09-14       Impact factor: 6.829

9.  Peri-infarct depolarizations during focal ischemia in the awake Spontaneously Hypertensive Rat. Minimizing anesthesia confounds in experimental stroke.

Authors:  K Kudo; L Zhao; T S Nowak
Journal:  Neuroscience       Date:  2016-03-26       Impact factor: 3.590

Review 10.  Clinical Development and Implementation of an Institutional Guideline for Prospective EEG Monitoring and Reporting of Delayed Cerebral Ischemia.

Authors:  Carlos F Muniz; Apeksha V Shenoy; Kathryn L OʼConnor; Sophia C Bechek; Emily J Boyle; Mary M Guanci; Tara M Tehan; Sahar F Zafar; Andrew J Cole; Aman B Patel; Michael B Westover; Eric S Rosenthal
Journal:  J Clin Neurophysiol       Date:  2016-06       Impact factor: 2.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.